GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,070.00
-10.00 (-0.25%)
At close: Dec 5, 2025

GeneBioTech Co. ,Ltd Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
35,04528,32937,54234,35645,11949,511
Upgrade
Market Cap Growth
14.33%-24.54%9.27%-23.86%-8.87%2.31%
Upgrade
Enterprise Value
27,03219,77630,94031,10535,59041,859
Upgrade
Last Close Price
4070.003290.004360.003990.005240.005716.70
Upgrade
PE Ratio
9.529.8914.4922.55--
Upgrade
PS Ratio
0.380.340.470.420.720.84
Upgrade
PB Ratio
0.650.560.780.751.030.98
Upgrade
P/TBV Ratio
0.660.560.790.771.051.12
Upgrade
P/FCF Ratio
24.57-5.49---
Upgrade
P/OCF Ratio
6.20-5.10--19.87
Upgrade
EV/Sales Ratio
0.290.240.390.380.570.71
Upgrade
EV/EBITDA Ratio
4.653.795.8310.9444.9844.05
Upgrade
EV/EBIT Ratio
6.105.157.7919.98--
Upgrade
EV/FCF Ratio
18.95-4.52---
Upgrade
Debt / Equity Ratio
0.260.310.260.280.230.11
Upgrade
Debt / EBITDA Ratio
2.433.052.354.5813.025.90
Upgrade
Debt / FCF Ratio
9.90-1.83---
Upgrade
Asset Turnover
1.251.201.221.331.030.91
Upgrade
Inventory Turnover
4.914.374.354.974.594.69
Upgrade
Quick Ratio
2.442.022.331.911.994.44
Upgrade
Current Ratio
3.533.043.402.912.985.92
Upgrade
Return on Equity (ROE)
7.05%5.77%5.51%3.40%-1.03%-0.13%
Upgrade
Return on Assets (ROA)
3.77%3.48%3.82%1.56%-0.46%-1.05%
Upgrade
Return on Capital (ROIC)
4.12%3.76%4.15%1.72%-0.51%-1.18%
Upgrade
Return on Capital Employed (ROCE)
7.40%7.20%7.70%3.20%-1.00%-2.00%
Upgrade
Earnings Yield
10.51%10.11%6.90%4.43%-1.07%-4.73%
Upgrade
FCF Yield
4.07%-5.52%18.21%-14.07%-12.89%-3.83%
Upgrade
Dividend Yield
-----0.53%
Upgrade
Buyback Yield / Dilution
0.02%-----
Upgrade
Total Shareholder Return
0.02%----0.53%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.